NVSEF
Market cap | $218.82 Billion |
---|---|
Enterprise Value | $230.74 Billion |
Dividend Yield | $3.3 (0.0%) |
Earnings per Share | $7.1 |
Beta | 0.0 |
Outstanding Shares | 2,277,477,752 |
Avg 30 Day Volume | 125,581 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 14.74 |
---|---|
PEG | 3.08 |
Price to Sales | 4.78 |
Price to Book Ratio | 4.78 |
Enterprise Value to Revenue | 4.95 |
Enterprise Value to EBIT | 22.43 |
Enterprise Value to Net Income | 15 |
Total Debt to Enterprise | 0.11 |
Debt to Equity | 0.56 |
No data
No data
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segm...